Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 May;41(5):1158–1161. doi: 10.1128/aac.41.5.1158

Susceptibility to beta-lactam antibiotics of Pseudomonas aeruginosa overproducing penicillin-binding protein 3.

X Liao 1, R E Hancock 1
PMCID: PMC163870  PMID: 9145889

Abstract

By using a broad-host-range vector, pUCP27, the Pseudomonas aeruginosa and Escherichia coli pbpB genes, which encode penicillin-binding protein 3 (PBP3), were separately overexpressed in a P. aeruginosa strain, PAO4089, that is deficient in producing chromosomal beta-lactamase. Susceptibility studies indicated that overproduction of the P. aeruginosa PBP3 in PAO4089 resulted in twofold-increased resistance to aztreonam, fourfold-increased resistance to cefepime and cefsulodin, and eightfold-increased resistance to ceftazidime, whereas overproduction of the P. aeruginosa PBP3 in PAO4089 did not affect susceptibility to PBP1-targeted cephaloridine or PBP2-targeted imipenem. Similar results were obtained with PAO4089 overproducing E. coli PBP3, with the exception that there was no influence on the MICs or minimal bactericidal concentrations of cefsulodin and cefepime, which have very low affinities for E. coli PBP3. These data are consistent with the conclusion that PBP3 has to achieve a certain level of saturation, with beta-lactams targeted to this protein, to result in cell inhibition or death.

Full Text

The Full Text of this article is available as a PDF (629.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellido F., Pechère J. C., Hancock R. E. Reevaluation of the factors involved in the efficacy of new beta-lactams against Enterobacter cloacae. Antimicrob Agents Chemother. 1991 Jan;35(1):73–78. doi: 10.1128/aac.35.1.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Godfrey A. J., Bryan L. E., Rabin H. R. beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment. Antimicrob Agents Chemother. 1981 May;19(5):705–711. doi: 10.1128/aac.19.5.705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Liao X., Charlebois I., Ouellet C., Morency M. J., Dewar K., Lightfoot J., Foster J., Siehnel R., Schweizer H., Lam J. S. Physical mapping of 32 genetic markers on the Pseudomonas aeruginosa PAO1 chromosome. Microbiology. 1996 Jan;142(Pt 1):79–86. doi: 10.1099/13500872-142-1-79. [DOI] [PubMed] [Google Scholar]
  4. Liao X., Hancock R. E. Cloning and characterization of the Pseudomonas aeruginosa pbpB gene encoding penicillin-binding protein 3. Antimicrob Agents Chemother. 1995 Aug;39(8):1871–1874. doi: 10.1128/aac.39.8.1871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Maejima T., Inoue M., Mitsuhashi S. In vitro antibacterial activity of KP-736, a new cephem antibiotic. Antimicrob Agents Chemother. 1991 Jan;35(1):104–110. doi: 10.1128/aac.35.1.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Nikaido H., Normark S. Sensitivity of Escherichia coli to various beta-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic beta-lactamases: a quantitative predictive treatment. Mol Microbiol. 1987 Jul;1(1):29–36. doi: 10.1111/j.1365-2958.1987.tb00523.x. [DOI] [PubMed] [Google Scholar]
  7. Parr T. R., Jr, Chan L., Bayer A. S. Effects of inner-membrane-associated beta-lactamase on penicillin-binding protein assays. Study of stably derepressed Pseudomonas aeruginosa strains from experimental endocarditis. Chemotherapy. 1988;34(6):478–483. doi: 10.1159/000238612. [DOI] [PubMed] [Google Scholar]
  8. Pucci M. J., Boice-Sowek J., Kessler R. E., Dougherty T. J. Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329. Antimicrob Agents Chemother. 1991 Nov;35(11):2312–2317. doi: 10.1128/aac.35.11.2312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Satta G., Cornaglia G., Mazzariol A., Golini G., Valisena S., Fontana R. Target for bacteriostatic and bactericidal activities of beta-lactam antibiotics against Escherichia coli resides in different penicillin-binding proteins. Antimicrob Agents Chemother. 1995 Apr;39(4):812–818. doi: 10.1128/aac.39.4.812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Schweizer H. P. A method for construction of bacterial hosts for lac-based cloning and expression vectors: alpha-complementation and regulated expression. Biotechniques. 1994 Sep;17(3):452-4, 456. [PubMed] [Google Scholar]
  11. Schweizer H. P. Escherichia-Pseudomonas shuttle vectors derived from pUC18/19. Gene. 1991 Jan 2;97(1):109–121. doi: 10.1016/0378-1119(91)90016-5. [DOI] [PubMed] [Google Scholar]
  12. Spratt B. G., Hedge P. J., te Heesen S., Edelman A., Broome-Smith J. K. Kanamycin-resistant vectors that are analogues of plasmids pUC8, pUC9, pEMBL8 and pEMBL9. Gene. 1986;41(2-3):337–342. doi: 10.1016/0378-1119(86)90117-4. [DOI] [PubMed] [Google Scholar]
  13. Spratt B. G. Properties of the penicillin-binding proteins of Escherichia coli K12,. Eur J Biochem. 1977 Jan;72(2):341–352. doi: 10.1111/j.1432-1033.1977.tb11258.x. [DOI] [PubMed] [Google Scholar]
  14. Watanabe N., Katsu K. Bactericidal activity of cefclidin (E1040) against Pseudomonas aeruginosa under conditions simulating plasma pharmacokinetics: lack of development of chromosomally-mediated resistance to beta-lactams. J Antimicrob Chemother. 1992 Oct;30(4):475–487. doi: 10.1093/jac/30.4.475. [DOI] [PubMed] [Google Scholar]
  15. Zimmermann W., Rosselet A. Function of the outer membrane of Escherichia coli as a permeability barrier to beta-lactam antibiotics. Antimicrob Agents Chemother. 1977 Sep;12(3):368–372. doi: 10.1128/aac.12.3.368. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES